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Edited by Barry HalliwellAbstract Uncoupling protein-3 (UCP3) has been suggested to
protect against lipid-induced oxidative damage. Therefore, we
studied intramuscular lipid peroxide levels and high-fat diet in-
duced alterations in muscle lipid metabolism of UCP3-ablated
mice.
UCP3/ mice showed 3-fold higher levels of intramuscular
lipid peroxides upon standard chow feeding, compared to wild-
type littermates. Remarkably, this diﬀerence was no longer
apparent on the high-fat diet. However, upon high-fat feeding,
intramuscular triacylglycerol levels were 50% lower in
UCP3/ mice, in comparison to UCP3+/+ animals. Succinate
dehydrogenase activity, and total protein content of the muscle
fatty acid transporter FAT/CD36 were however similar between
UCP3/ and UCP3+/+ mice.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Since the discovery of uncoupling protein-3 (UCP3) in 1997,
many studies were devoted to the function of this UCP1 homo-
logue, which is primarily expressed in skeletal muscle. How-
ever, its physiological role remains to be established. The
most supported hypotheses concerning the physiological func-
tion of UCP3 state that this protein is either involved in the
protection against reactive oxygen species (ROS) or has a role
in fat metabolism. UCP3 is suggested to limit the production
of ROS by mediating a mechanism of mild uncoupling result-
ing in a decrease in protonmotive force, thereby diminishing
superoxide production [1]. Although there is support for a role
of UCP3 in ROS defense [1–4], studies have also consistently*Corresponding author. Fax: +31 0 43 3670976.
E-mail address: j.hoeks@hb.unimaas.nl (J. Hoeks).
1 Present address: Department of Molecular Pharmacology, Astra-
Zeneca R&D, Mo¨lndal, Sweden.
0014-5793/$32.00  2006 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2006.01.059observed that UCP3 content is increased when the supply of
lipids to the muscle exceeds the capacity to oxidize these lipids
[5–9], and is decreased when fatty acid oxidation is improved
[10,11] or lipid supply to the mitochondria is lowered [12]. To-
gether, these data suggest that UCP3 may speciﬁcally have a
function in the defense against excessive ROS production
under conditions of high-fatty acid supply to the mitochon-
dria. In that context, we previously hypothesized that UCP3
is involved in the outward translocation of non-metabolizable
fatty acid anions, to protect mitochondria from the deleterious
eﬀects of intramitochondrial fatty acid accumulation [13].
When the fatty acid supply to the mitochondria exceeds the
oxidative capacity, and the load of fatty acids on the mito-
chondrial membrane increases, neutral fatty acids can enter
the inner mitochondrial membrane and reach the matrix side
through ﬂip-ﬂop [14], where they will be deprotonated due to
the proton gradient across the inner mitochondrial membrane.
Because the mitochondrial membrane is impermeable to the
resulting fatty acid anions [15], and because the fatty acids can-
not be oxidized due to the lack of activation by acyl-CoA syn-
thase, they are trapped at the matrix side of the inner
mitochondrial membrane. Since the mitochondrial matrix is
also the site where ROS is produced, these fatty acid anions
are highly susceptible to peroxidation by the oxygen radicals.
The resulting lipid peroxides are potentially hazardous to the
mitochondrial proteins and DNA and could induce mitochon-
drial damage and dysfunction. By facilitating the export of
these fatty acid anions, UCP3 could be involved in the protec-
tion of the mitochondria against lipid-induced oxidative dam-
age. In a variant of this hypothesis, Goglia and Skulachev [16]
suggested that UCP3 exports lipid peroxides, with the same
protective function. Together with the anti-ROS hypothesis
of the group of Brand [1,17], these three hypothesis all predict
that a lack of UCP3 would result in lipid-induced oxidative
damage.
In this context, insulin resistant subjects and type 2 diabetics
are characterized by high fatty acid levels and low oxidative
capacity, theoretically demanding a high UCP3 protein con-
tent to protect mitochondria against lipid-induced oxidative
damage. Interestingly, however, type 2 diabetic patients are
characterized by a 50% reduction in UCP3 protein content
[18], increased levels of lipid peroxides [19] and mitochondrialblished by Elsevier B.V. All rights reserved.
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suggest that a low level of UCP3 fails to protect fatty acids
against ROS-induced peroxidation, ultimately leading to li-
pid-induced mitochondrial damage in type 2 diabetic patients
[25].
Therefore, we anticipated that lack of UCP3 would lead to
increased levels of muscular lipid peroxides under diabetogenic
conditions, such as on a high-fat diet and investigated the eﬀect
of UCP3 ablation on intramuscular lipid peroxide levels and
high-fat diet induced alterations in muscle lipid metabolism.2. Methods
2.1. Animals
Sixteen UCP3-ablated (aged: 12.2 ± 1.3 weeks) and 12 wild-
type littermates (aged: 12.8 ± 1.2 weeks), original breeding
pairs a gift from GlaxoSmithKline (Harlow, UK), were used
in the present study [26]. The mice were housed individually
on a 12:12 h light–dark cycle (light from 7:00 a.m. to 7:00
p.m.), at 21–22 C and subjected to a four week–week dietary
intervention. During the experiments, mice had free access to
tap water. All experiments were approved by the Institutional
Animal Care and Use Committee of the Maastricht University
and complied with the principles of laboratory animal care.
2.2. Diets
UCP3 ablated mice (UCP3/) and their wild-type litter-
mates (UCP3+/+) were randomly divided into a total of four
groups. Eight UCP3/ and six UCP3+/+ mice had unlimited
access to standard chow diet (ssniﬀ r/m-h 10 mm, Bio Ser-
vices, Uden, The Netherlands, 16.3 MJ/kg, 7.5 EN% from
fat) for the duration of four weeks. Another eight UCP3/
and six UCP3+/+ mice were maintained on a high-fat diet
(4031.10, Hope Farms, Woerden, The Netherlands, 19.8 MJ/
kg, 45 EN% from fat), which was also provided ad libitum.
In the high-fat diet, the fat component was comprised of
C16:0 (25%), C18:0 (34%), C18:1 (33%), C18:2 (3%)
and C24:0 (5%). Food intake and body mass were recorded.
2.3. Tissue sampling
After the four-week dietary intervention period, tissue dis-
section was performed under general anesthesia (1.5–2.0% hal-
othane in O2 and N2O [3:1, 4.0 l/min]). Mice were deprived
from food approximately 8 h prior to tissue sampling. For his-
tological analysis, the mid-belly region of the left tibialis ante-
rior muscle was dissected and freed from any visible fat and
blood, embedded in Tissue-Tek (Sakura Finetek, Zoeterwo-
ude, The Netherlands) and rapidly frozen in liquid nitrogen-
cooled isopentane (2-methyl-butane, Fluka, Zwijndrecht, The
Netherlands). The tibialis anterior muscle of the contralateral
leg was dissected and immediately frozen in liquid nitrogen
for the determination of lipid hydroperoxide (LPO) levels.
All samples were stored at 80 C until further analysis.
2.4. Determination of intramuscular LPO
Snap-frozen tissues in liquid nitrogen were pulverized during
three min at 1800 rpm in a Braun Mikro-dismembrator
homogeniser type U (Braun Biotech Int., Melsungen, Ger-
many) using a PTFE-coated steel bead of 10 mm in diameter,
next suspended 1:3 (wt/vol) in phosphate-buﬀered saline, pH7.4, supplemented with 4 mM butylated hydroxytoluene and
further homogenized at 4 C using a Teﬂon hand-held pestle
in an Eppendorf vial. The concentration of LPO of the homog-
enate was determined after incubation with 35 U/ml catalase
for two min at room temperature to inactivate any hydrogen
peroxide, by the ferric iron-dependent increase in absorbance
of xylenol-orange at 560 nm (LPO apparent e = 0.08904
lM1 cm1, experimentally assessed using freshly-made re-
agents only and standard curves of t-butyl peroxide and cu-
mene peroxide) essentially as described by Nourooz-Zadeh
et al. [27] using the sample treated by 0.9 mM tris(2-carboxy-
ethyl)phosphine to reduce the LPO to their respective alcohols
as the reference.
2.5. Histological analysis
Cryosections (5 lm) were thaw mounted on uncoated pre-
cleaned (96% ethanol) glass slides. Immediately after mounting,
air-dried, fresh cryosections were stained for intramuscular
triacylglycerols (IMTG) by Oil Red O staining (ORO) [28]
combined with immunolabeling of the basal membrane marker
laminin, to allow quantiﬁcation of IMTG. Serial sections were
stained for activity of succinate dehydrogenase (SDH), also
known as complex II in the electron transport chain, to deter-
mine the oxidative capacity of skeletal muscle, largely accord-
ing to [29].
2.6. IMTG analysis
Brieﬂy, cryosections were ﬁxed in 3.7% formaldehyde for
1 h. Then the sections were treated with 0.5% Triton X-100
in PBS for 5 min, and washed three times with PBS. Thereaf-
ter, sections were incubated for 30 min with a polyclonal rabbit
antibody against the basement membrane protein laminin (Sig-
ma–Aldrich, St. Louis, MO, USA, 1:50 dilution in PBS) to
visualize individual cell membranes followed by a 30 min incu-
bation with a FITC-conjugated goat anti-rabbit (Southern
Biotechnologies Associates, ITK, Uithoorn, The Netherlands;
1:80 dilution in PBS). After washing with PBS, glass slides
were immersed in the ORO working solution for 30 min for
the detection of lipid droplets (17) and rinsed three times with
deionized water for 30 s followed by 10 min of washing with
running tap water. Stained sections were embedded in Mowiol.
2.7. SDH activity analysis
Cryosections were incubated in a 0.2 M sodium phosphate
buﬀer containing 0.1 M succinic acid (Sigma–Aldrich) and
1.2 mM nitro-blue tetrazolium (Sigma–Aldrich). Incubation
was performed at a strictly controlled temperature of 37 C
for the duration of 60 min. Next, sections were shortly rinsed
with deionized water followed by three successive exchanges
in 30%, 60% and 90% acetone in deionized water, respectively.
SDH-stained sections were air-dried for 15 min. Thereafter,
also these sections were incubated for 30 min with the lami-
nin-antibody and the FITC-conjugated secondary antibody,
respectively, to visualize the cell membranes. Stained sections
were embedded in Mowiol. Following this procedure sites of
high SDH activity are colored gray-blue whereas low SDH
activity results in a pale color [29].
2.8. Image capturing, processing, and analysis
All sections were examined using a Nikon E800 ﬂuorescence
microscope (Nikon Instruments Europe B.V., Badhoevedorp,
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color charge-coupled device camera. Multiple random images
were captured for every single color (red and green) in case
of the ORO and in bright ﬁeld for the SDH activity staining.
The ﬂuorescent signal representing the cellular membrane in
the SDH stained sections was grabbed in the appropriate
channel and SDH activity was imaged using bright ﬁeld. Both
images, as well as the merged overlay were saved. All sections
were processed and analyzed using Lucia GF 4.80 software
(Nikon, Du¨sseldorf, Germany). Special care was taken to use
the same camera settings (gain and exposure time, and voltage
and diaphragm in case of bright ﬁeld) while grabbing all
images. For both SDH and IMTG >120 cells per muscle were
analyzed.2.9. IMTG
All images were analyzed for the lipid droplet over myocyte
area fraction. To this end, a semiautomatic macro was written
that allowed: (1) autodetection of the cellular membrane (iden-
tiﬁed in the green channel); (2) measurement of the area covered
by the measured myocytes; and (3) measurement of the area
covered by lipid droplets (identiﬁed in the red channel). The
area fraction was computed by dividing the area covered by
lipid droplets (in lm2) by the cell surface of the measured
myocytes (in lm2). The mean area fraction thus reﬂects the
percentage of the total measured cell surface covered by lipid
droplets.2.10. SDH activity
Like in the IMTG analyses, a semiautomatic macro was
used to identify the cellular membrane. The bright-ﬁeld image
of SDH activity was converted to 8-bits grayscale after which
integral optical density of every pixel in individual muscle cells
was measured. The mean optical density of every individual
cell was computed and used as a semi-quantative read-out
for SDH activity. Similar methods have previously been shown
to correlate well with whole muscle homogenate spectrophoto-
metrical analysis of SDH activity [30,31].2.11. Western blot analysis of FAT/CD36
Muscle homogenates were analyzed for the muscle fatty acid
transporter FAT/CD36 by Western blotting according to the
procedure described by Keizer et al. [32]. After electrophoresis
and blotting, nitrocellulose membranes were blocked for
20 min with 5% non-fat dried milk in 0.05% Tween 20/PBS
and incubated with a mouse IgA monoclonal antibody raised
against mouse FAT/CD36 (MAB1258-Chemicon, Invitrogen,
Breda, The Netherlands) 1:10000 in blocking buﬀer. After
the primary antibody incubation, the membranes were incu-
bated for 60 min with a horseradish peroxidase-conjugated
rabbit anti-mouse IgA (Southern Biotechnology Associates,
ITK, Uithoorn, The Netherlands) at a dilution of 1:5000 in
blocking buﬀer. The membranes were then washed for 1.5 h
in 0.05% Tween 20/PBS and again for 10 min in PBS. Subse-
quently, they were treated for 1 min with enhanced chemilumi-
nescence substrate (Super Signal West Dura Extended
Duration Substrate; Pierce/Perbio Science, Etten-Leur, The
Netherlands). Finally, nitrocellulose membranes were exposed
to X-ray ﬁlm (CL-Xposure Film; Pierce/Perbio Science) for 1
min and analyzed by densitometry using Imagemaster (Phar-
macia Biotech).2.12. Statistical analysis
Results are presented as means ± S.E.M. Diﬀerences within
animals were analyzed by the Wilcoxon signed-rank test for
paired samples. Diﬀerences between genotypes were evaluated
by the Mann–Whitney test for independent samples. Outcomes
were regarded as statistically signiﬁcant if P < 0.05.3. Results
3.1. Body mass and food intake
Initial body mass in the chow group was not statistically dif-
ferent between genotypes (20.6 ± 1.0 vs. 24.6 ± 1.9 g in
UCP3/ and UCP3+/+ mice, respectively, P = 0.14). Four
weeks of chow feeding did not change body mass, neither in
UCP3/ nor in UCP3+/+ animals (by 0.3 ± 0.6 vs.
0.5 ± 1.1 g in UCP3/ and UCP3+/+ animals, respectively,
NS). Gross energy intake during four weeks of chow feeding
was signiﬁcantly lower in UCP3/ animals, compared to their
wild-type littermates (1693 ± 63 vs. 1874 ± 47 kJ/4 weeks,
P = 0.043). The gross energy intake positively correlated with
initial body mass (r = 0.53; P = 0.052) and when expressed
per gram of initial body mass, gross energy intake was not sig-
niﬁcantly diﬀerent between the groups (UCP3/: 82.9 ± 3.5;
UCP3+/+: 78.6 ± 6.2 kJ/g/4 weeks, P = 0.49, NS).
Initial body mass in the HF group was similar between
UCP3/ and UCP3+/+ mice (21.4 ± 1.4 vs. 24.4 ± 1.8 g,
respectively, P = 0.18). Four weeks of HF feeding signiﬁ-
cantly increased body mass in both genotypes (by
1.6 ± 0.4 g [P = 0.012] in UCP3/ and by 2.4 ± 1.0 g
[P = 0.046] in UCP3+/+). The increase in body mass upon
HF feeding, was not diﬀerent between the two genotypes
(P = 0.76). Gross energy intake upon HF diet was compara-
ble in UCP3/ and UCP3+/+ mice (1929 ± 82 vs.
2189 ± 107 kJ/4 weeks, respectively, P = 0.11), and correlated
with initial body mass (r = 0.74; P = 0.002). Gross energy in-
take per gram of initial body mass was similar between geno-
types (UCP3/: 91.7 ± 4.0; UCP3+/+: 91.6 ± 6.1 kJ/g/4
weeks, P = 0.85, NS).
3.2. Intramuscular LPO and triacylglycerol levels
UCP3/ animals (n = 8) showed signiﬁcantly higher levels
of intramuscular LPO upon chow feeding, as compared to
UCP3+/+ (n = 6) mice (38.2 ± 11.2 vs. 12.5 ± 0.9 nmol/g wet
weight, P = 0.001). Surprisingly, 4 weeks of high-fat feeding re-
sulted in similar LPO levels in UCP3/ vs. UCP3+/+ mice
(13.6 ± 3.2 [n = 8] vs. 16.2 ± 5.1 nmol/g wet weight [n = 6],
respectively, P = 0.85, NS; Fig. 1).
Upon chow feeding, no diﬀerences in IMTG levels (Fig. 2)
were found between UCP3/ (n = 8) and UCP3+/+ (n = 6) ani-
mals (0.68 ± 0.44% vs. 0.72 ± 0.32% of the cell surface covered
by lipid droplets, respectively, P = 0.70, NS). After four weeks
of HF diet, IMTG levels were signiﬁcantly lower in the
UCP3/ (n = 8) animals compared to their wild-type (n = 5)
littermates (1.39 ± 0.44% vs. 3.01 ± 0.35%, respectively,
P = 0.019).
3.3. Oxidative capacity
Oxidative capacity, measured as SDH activity, was similar
in UCP3/ and UCP3+/+ mice, after chow (UCP3/:
0.32 ± 0.05 [n = 7] vs. UCP3+/+: 0.31 ± 0.06 AU [n = 4]) as well
Fig. 1. Intramuscular LPO levels in m. tibialis anterior upon chow and
high-fat (HF) feeding. *P < 0.05 compared to UCP3+/+ upon chow
feeding.
Fig. 2. IMTG levels in m. tibialis anterior after 4 weeks of chow or
high-fat (HF) feeding. #P < 0.05 compared to UCP3+/+ upon HF
feeding.
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0.39 ± 0.06 AU [n = 5]).
3.4. Fatty acid transporter FAT/CD36
Protein levels of FAT/CD36, determined by Western blot-
ting, were similar between UCP3/ (n = 4) and UCP3+/+
(n = 5) mice after chow feeding and averaged 124 ± 25 and
101 ± 24 AU, respectively. Also after 4 weeks of high-fat diet,
no signiﬁcant diﬀerences were detected between UCP3/
(73 ± 19 AU, n = 8) and UCP3+/+ (86 ± 13 AU, n = 5) mice.4. Discussion
The physiological function of UCP3 is still under debate.
However, several lines of evidence point towards a role for this
mitochondrial protein in protection against lipid-induced oxi-
dative damage to mitochondria. We have previously hypothe-
sized that UCP3 fulﬁls this protective role in skeletal musclemitochondria by exporting non-metabolizable fatty acid an-
ions away from the side of the mitochondrial matrix, a func-
tion especially important in situations of increased lipid
supply. ROS, regarded as inevitable by-products of normal
aerobic metabolism, can peroxidize these fatty acid anions,
giving rise to toxic and highly reactive lipid peroxides that
would be trapped in the inner mitochondrial membrane and/
or matrix. In addition to this putative role of UCP3, it has also
been hypothesized that UCP3, upon activation by lipid perox-
ides (such as 4-hydroxy-trans-2-nonenal, 4HNE), reduces ROS
production directly [1,3,17]. Indeed, Echtay et al. [1] showed
that 4HNE was able to uncouple skeletal muscle mitochondria
in the absence, but not in the presence of GDP, indicative of
UCP-mediated uncoupling. Moreover, the uncoupling eﬀect
of 4HNE was signiﬁcantly less in UCP3-ablated mice com-
pared to wild-type mitochondria [1]. Furthermore, GDP did
not prevent the stimulation of proton conductance in UCP3
ablated mice. Thus, the increased UCP3 activity upon lipid
peroxides, such as 4HNE, lowers protonmotive force and results
in a decrease in superoxide production, thereby providing a
simple feedback loop [17].
However, according to both hypotheses, UCP3 ablation
would lead to increased levels of lipid peroxides, especially
during lipid oversupply. Here we show that UCP3-ablated
mice display signiﬁcantly higher levels of intramuscular LPO
upon standard chow feeding. Surprisingly, however, no in-
crease in lipid peroxidation in UCP3/ mice was observed
on a high-fat diet, but under this condition, other adaptive
mechanisms seem to operate preventing further augmentation
of intramuscular lipid peroxides.
In addition to conﬁrm the previous ﬁnding that levels of li-
pid peroxides are increased in UCP3/ mice on a chow diet
[2], the present study remarkably showed that, UCP3/ mice
did not diﬀer in their levels of lipid peroxides upon a high-fat
diet, as would have been expected on the basis of the present
hypotheses on the physiological function of UCP3. This may
indicate that UCP3 is not important in the prevention of
ROS production under high-fat conditions. More likely, how-
ever, UCP3/ animals may display other protective mecha-
nisms to cope with the increased lipid supply and/or
increased ROS production. To elucidate that, we examined
whether UCP3/ mice on a high fat diet were able to limit
the storage of muscular fatty acids. To this end, we measured
IMTG levels by ORO staining in UCP3/ and UCP3+/+ mice,
both after chow and high-fat feeding. Surprisingly, UCP3/
mice were indeed characterized by markedly lower IMTG lev-
els (54%) compared to their wild-type littermates upon 4
weeks of high-fat diet.
The diﬀerence in lipid peroxidation between UCP3/ and
UCP3+/+ mice upon chow feeding, would be maintained
(P = 0.06) under high-fat conditions if the muscular lipid per-
oxidation is expressed per unit of muscular lipid. However, our
data clearly illustrate that this is not directly due to the lack of
protection by UCP3, but due to a remarkable lowering of the
amount of intramuscular lipids. In fact, IMTG levels in
UCP3/ mice fed a high-fat diet were only marginally higher
compared to chow-fed UCP3/ mice, whereas in wild-type
animals, 4 weeks of HF diet caused a 4.4-fold increase in
IMTG levels. These diﬀerences could not be accounted for
by diﬀerences in muscle ﬁber type distribution (data not
shown). A reduction in IMTG levels can, based on the putative
functions of UCP3, not be directly deduced from the lack of
J. Hoeks et al. / FEBS Letters 580 (2006) 1371–1375 1375UCP3 and it is therefore tempting to speculate that the reduc-
tion in IMTG represents an adaptive mechanism to limit per-
oxidation of muscular fatty acids by the increased ROS
production that has been observed in muscle of UCP3/ mice
on a regular diet [2,4].
To address the question how UCP3/ mice are capable of
limiting intramuscular fat accumulation upon a high-fat diet,
we examined oxidative capacity in these mice. However, we
could not detect any diﬀerences in oxidative capacity between
UCP3/ and UCP3+/+ mice, neither on a chow nor on a high-
fat diet. These results are compatible with the ﬁnding that
UCP3 ablation on a chow diet had no eﬀect on markers of
fatty acid oxidation [33], as well as with the results of Vidal-
Puig et al. [4] who were unable to show a diﬀerence in fatty
acid oxidation between UCP3/ and UCP3+/+ mice, neither
in sedentary nor in exercised animals. Moreover, in the fasted
state an impaired, in contrast to improved, fat oxidation in
UCP3/ mice was observed [34].
Vidal-Puig et al. [4] reported earlier that UCP3/ mice dis-
play increased plasma free fatty acid levels, when challenged
with a high-fat diet. This ﬁnding indicates that the lower
IMTG levels that we observed in UCP3/ mice upon high-
fat feeding, cannot be explained by a diminished supply of
fatty acids to the muscle, but is suggestive for a decreased fat
uptake in muscle. To this end, we determined protein levels
of the muscle fatty acid transporter, FAT/CD36, which has
been shown to be involved in the uptake of plasma free fatty
acids into skeletal muscle. Nevertheless, we could not detect
any diﬀerences in the protein levels of FAT/CD36 between
UCP3/ and UCP3+/+ mice. However, controlled measure-
ments with labeled fatty acids may be required to exclude
the possibility of diminished fatty acid uptake in skeletal mus-
cle from UCP3/ mice upon high-fat feeding.
In summary, UCP3/ mice show signiﬁcantly higher levels
of intramuscular lipid peroxides upon standard chow feeding,
as compared to their wild-type littermates. Remarkably how-
ever, no diﬀerences were observed in the levels of lipid perox-
ides after 4 weeks of a HF diet. The latter observation was
accompanied by the ﬁnding that, upon HF feeding, IMTG lev-
els were markedly lower in UCP3/ mice, in comparison to
the UCP3+/+ animals. Diﬀerences in oxidative capacity, as as-
sessed by SDH activity, or the protein levels of FAT/CD36
could not account for the lower IMTG levels, observed in
UCP3-ablated mice on a HF diet. Therefore, the exact under-
lying (molecular) mechanism for the reduced IMTG levels in
UCP3/ mice remains to be established.
These data also indicate that the UCP3/mouse may not be
the best model to answer the question whether low UCP3 levels
will lead to lipid-induced mitochondrial damage and contribute
to the pathogenesis of type 2 diabetes, as we have previously
suggested [25]. Such information, however, is eagerly awaited
since insulin resistant subjects and/or type 2 diabetic patients
are characterized by a 50% reduction of UCP3 protein content
[18] and are also characterized by increased levels of lipid perox-
idation [19] and mitochondrial damage [20], but may require
novel methodologies such as siRNA to acutely suppress
UCP3. The adaptive capacity to reduce IMTG levels in
UCP3/mice may also explain why these mice have no appar-
ent phenotype (such as obesity and diabetes).Acknowledgements: MSc. J. Hoeks was supported by a grant from the
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